Lineage Cell Therapeutics In shares owned by Two Sigma Advisers
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Two Sigma Advisers
from 13F filings
Historical chart of Two Sigma Advisers investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Two Sigma Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Two Sigma Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $20k | 12k | 1.69 |
| 2025-06-30 | $13k | 15k | 0.91 |
| 2025-03-31 | $101k | 223k | 0.45 |
| 2024-12-31 | $44k | 87k | 0.50 |
| 2024-09-30 | $19k | 21k | 0.91 |
| 2024-06-30 | $22k | 23k | 1.00 |
| 2024-03-31 | $48k | 32k | 1.48 |
| 2023-12-31 | $41k | 38k | 1.09 |
| 2023-09-30 | $46k | 39k | 1.18 |
| 2023-06-30 | $70k | 50k | 1.41 |
| 2023-03-31 | $101k | 67k | 1.50 |
| 2022-12-31 | $104k | 89k | 1.17 |
| 2022-09-30 | $249k | 220k | 1.13 |
| 2022-06-30 | $416k | 263k | 1.58 |
| 2022-03-31 | $948k | 616k | 1.54 |
| 2021-12-31 | $2.7M | 1.1M | 2.45 |
| 2021-09-30 | $2.8M | 1.1M | 2.52 |
| 2021-06-30 | $5.2M | 1.8M | 2.85 |
| 2021-03-31 | $3.8M | 1.6M | 2.35 |
| 2020-12-31 | $897k | 510k | 1.76 |
| 2020-09-30 | $316k | 338k | 0.94 |
| 2020-06-30 | $254k | 292k | 0.87 |
| 2020-03-31 | $193k | 234k | 0.83 |
| 2019-12-31 | $219k | 246k | 0.89 |
| 2019-09-30 | $184k | 188k | 0.98 |